WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED FEBRUARY 15, 2012]
HOLI [Hollysys Automation Technologies] 6-K: (Original Filing)
[Hollysys Automation Technologies Reports Unaudited Financial Results for the Fiscal Year 2012 Second Quarter Ended December 31, 2011 Q2 Financial Highlights · Quarterly revenues of $80.3 million, representing an increase of 8.0% compared to $74.4 million year-over-year. · Gross margin at 38.5%, as compared to 36.0% year-over-year, and 37.8% quarter-over-quarter · Non-GAAP net income attributable to Hollysys of $20.4 million,]
HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Reports Unaudited Financial Results for
[Hollysys Automation Technologies Reports Unaudited Financial Results for the Fiscal Year 2012 Second Quarter Ended December 31, 2011 Q2 Financial Highlights · Quarterly revenues of $80.3 million, representing an increase of 8.0% compared to $74.4 million year-over-year. · Gross margin at 38.5%, as compared to 36.0% year-over-year, and 37.8% quarter-over-quarter · Non-GAAP net income attributable to Hollysys of $20.4 million,]
